Evidence mapPaperPMID 31318090Full record

ArticleInternational journal of geriatric psychiatry2019

Cognitive and functional progression of dementia in two longitudinal studies.

Yuwei Wang, Miriam L Haaksma, Inez H G B Ramakers, Frans R J Verhey, Wiesje M van de Flier, Philip Scheltens, Ingrid van Maurik, Marcel G M Olde Rikkert, Jeannie-Marie S Leoutsakos, René J F Melis

Abstract read
In one paragraph

Article in International journal of geriatric psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020
    Article
  7. Article
  8. Cognitive and functional progression of dementia in two longitudinal studies.International journal of geriatric psychiatry · 2019
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuwei WangDepartment of Geriatric Medicine, Radboudumc Alzheimer Center, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-1482-7039
Miriam L HaaksmaDepartment of Geriatric Medicine, Radboudumc Alzheimer Center, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-3518-9152
Inez H G B RamakersDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands.
Frans R J VerheyDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University, Maastricht, The Netherlands.
Wiesje M van de FlierAlzheimer Center Amsterdam, Department of Neurology, Department of Epidemiology and Biostatistics, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Philip ScheltensAlzheimer Center Amsterdam, Department of Neurology, Department of Epidemiology and Biostatistics, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Ingrid van MaurikAlzheimer Center Amsterdam, Department of Neurology, Department of Epidemiology and Biostatistics, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Marcel G M Olde RikkertDepartment of Geriatric Medicine, Radboudumc Alzheimer Center, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Jeannie-Marie S LeoutsakosDepartment of Psychiatry, Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1010-1046
René J F MelisDepartment of Geriatric Medicine, Radboudumc Alzheimer Center, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-7863-4738

Funding

NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · UNIVERSITY OF WASHINGTON · 1999 to 2005
$18.2M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · WASHINGTON UNIVERSITY · 1985 to 2005
$16.3M
VIRUS-INDUCED BRAIN PATHOLOGYP50AG005131 · UNIVERSITY OF CALIFORNIA SAN DIEGO · 1985 to 2005
$15.7M
SATTELITE DIAGNOSTIC AND TREATMENT CENTERP50AG005136 · UNIVERSITY OF WASHINGTON · 1985 to 2005
$15.1M
TAU ALTERATIONS IN ALZHEIMER'S AND RELATED DEMENTIASP50AG005134 · MASSACHUSETTS GENERAL HOSPITAL · 1985 to 2005
$12.3M
PROTEIN TRAFFICKING IN SPORADIC ALZHEIMER'S DISEASEP50AG008702 · COLUMBIA UNIV NEW YORK MORNINGSIDE · 1989 to 2005
$12.2M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · 1985 to 2005
$11.9M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · UNIVERSITY OF SOUTHERN CALIFORNIA · 1985 to 2005
$11.5M
TENSOR ATROPHY MEASURES FROM MRI IN NORMAL AGING /AD/FTDP50AG016574 · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · 1999 to 2005
$11.1M
SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · RUSH UNIVERSITY MEDICAL CENTER · 1991 to 2005
$10.7M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 1985 to 2005
$10.7M
'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · JOHNS HOPKINS UNIVERSITY · 1985 to 2005
$10.4M
NIA NIH HHS P30 AG008017NIA NIH HHS P30 AG008051NIA NIH HHS P30 AG010124NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG010133NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG012300NIA NIH HHS P30 AG013846NIA NIH HHS P30 AG013854NIA NIH HHS P30 AG019610NIA NIH HHS P30 AG028383NIA NIH HHS P30 AG035982NIA NIH HHS P30 AG049638NIA NIH HHS P30 AG053760NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG066514NIA NIH HHS P30 AG066515NIA NIH HHS P30 AG072973NIA NIH HHS P50 AG005131NIA NIH HHS P50 AG005133NIA NIH HHS P50 AG005134NIA NIH HHS P50 AG005136NIA NIH HHS P50 AG005138NIA NIH HHS P50 AG005142NIA NIH HHS P50 AG005146NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG008702NIA NIH HHS P50 AG016573NIA NIH HHS P50 AG016574NIA NIH HHS P50 AG023501NIA NIH HHS P50 AG025688NIA NIH HHS P50 AG033514NIA NIH HHS P50 AG047266NIA NIH HHS P50 AG047270NIA NIH HHS P50 AG047366NIA NIH HHS U01 AG016976NIA NIH HHS U24 AG072122
6 · The paper itself

Abstract

objectivesPrevious studies have identified several subgroups (ie, latent trajectories) with distinct disease progression among people with dementia. However, the methods and results were not always consistent. This study aims to perform a coordinated analysis of latent trajectories of cognitive and functional progression in dementia across two datasets.

methodsIncluded and analyzed using the same statistical approach were 1628 participants with dementia from the US National Alzheimer's Coordinating Center (NACC) and 331 participants with dementia from the Dutch Clinical Course of Cognition and Comorbidity study (4C-Study). Trajectories of cognition and instrumental activities of daily living (IADL) were modeled jointly in a parallel-process growth mixture model.

resultsCognition and IADL tended to decline in unison across the two samples. Slow decline in both domains was observed in 26% of the US sample and 74% of the Dutch sample. Rapid decline in cognition and IADL was observed in 7% of the US sample and 26% of the Dutch sample. The majority (67%) of the US sample showed moderate cognitive decline and rapid IADL decline.

conclusionsTrajectories of slow and rapid dementia progression were identified in both samples. Despite using the same statistical methods, the number of latent trajectories was not replicated and the relative class sizes differed considerably across datasets. These results call for careful consideration when comparing progression estimates in the literature. In addition, the observed discrepancy between cognitive and functional decline stresses the need to monitor dementia progression across multiple domains.

Indexed as

Activities of Daily LivingAgedAged, 80 and overCognitive DysfunctionComorbidityDementiaDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle Agedcognitioncoordinated analysisdaily functioningdementia progressiongrowth mixture modeltrajectory

Identifiers

PMID31318090
PMCPMC6803041

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.